Advertisement
Singapore markets closed
  • Straits Times Index

    3,176.51
    -11.15 (-0.35%)
     
  • Nikkei

    37,068.35
    -1,011.35 (-2.66%)
     
  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     
  • FTSE 100

    7,843.09
    -33.96 (-0.43%)
     
  • Bitcoin USD

    64,821.82
    +2,538.56 (+4.08%)
     
  • CMC Crypto 200

    1,339.16
    +26.53 (+2.06%)
     
  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     
  • Dow

    37,775.38
    +22.07 (+0.06%)
     
  • Nasdaq

    15,601.50
    -81.87 (-0.52%)
     
  • Gold

    2,397.10
    -0.90 (-0.04%)
     
  • Crude Oil

    82.37
    -0.36 (-0.44%)
     
  • 10-Yr Bond

    4.6100
    -0.0370 (-0.80%)
     
  • FTSE Bursa Malaysia

    1,547.57
    +2.81 (+0.18%)
     
  • Jakarta Composite Index

    7,087.32
    -79.50 (-1.11%)
     
  • PSE Index

    6,443.00
    -80.19 (-1.23%)
     

What’s behind Nektar Therapeutics’ ~38% Fall in June?

What’s behind Nektar Therapeutics’ ~38% Fall in June?

On June 27, Nektar Therapeutics (NKTR) ended the trading day at a closing price of $46.25. On the day, NKTR stock was trading ~164% higher than the 52-week low of $17.51 it reported on August 21, whereas the stock was trading ~59% lower than the 52-week high of $111.36 it reported on March 12. Currently, NKTR stock is trading lower than its 50-day moving average of $67.63 and its 200-day moving average of $79.32.